COVID-19 UPDATES
- Online cannabis sales jump 600% in Ontario following COVID-19 restrictions.
- Washington D.C. to allow medical cannabis deliveries during lockdown.
- US hemp groups ask federal regulators to include hemp farmers in COVID-19 relief.
- Coronavirus delays adult-use legalisation in Guam.
- Danish Medicines Agency puts all inspections on hold until the summer.
Highlights
- Virginia decriminalises cannabis but low-level penalties remain in place.
- Read key insights from The Oceania Cannabis Report: Second Edition.
- New DEA figures show more cannabis seizures but fewer cannabis arrests in 2019.
Europe
- German cannabis association calls on federal ministers to regulate product prices.
- DanCann secures US$3.48 million investment to develop its facility in Denmark.
- AMP German Cannabis Group obtains licences needed for European imports.
Canada
- Aurora plans to consolidate its shares to retain NYSE public listing.
- Cannabis retailers in Ottawa praise decision to allow cannabis deliveries.
- HEXO raises US$33 million in public offering.
USA
- Judge upholds temporary ban on recreational cannabis sales in Massachusetts.
- Florida hemp licence applications to open by 27 April.
- Montana activists sue state officials for the right to collect electronic signatures.
- Cannabis Beverage Association forms to educate policymakers and consumers.
- Molson Coors and HEXO form joint venture to explore non-alcoholic CBD beverages.

APAC
- Minister for Health praises LYPHE Group’s first Australian import into the UK.
- New Zealand’s Cannasouth announces opening of US$1.8 million share purchase plan.
- Sequoya Cannabis secures US$1.2 million investment from Australia’s MMJ Group.
Latam & Caribbean
- US court upholds US$4 million judgement in favour of El-Salvador-based CBD firm.
- BD Vida partners with Iowa manufacturer to deliver medical CBD products in Brazil.
Africa & Middle East
- Israeli cultivator passes microbial and pesticide testing without using irradiation.
- Labat Africa to acquire 70% of Biodata to expand available research infrastructure.
Health & Science
- Headache and migraine pain approximately halved by cannabis, finds new analysis.
- Cannabis ‘clinically meaningful’ in treating opioid withdrawal symptoms.
- Study finds that access to cannabis reduces opioid demand.
Psychedelics
- Researchers build human brain model to study the effects of psilocybin.
- Champignon Brands appoints former Red Bull Canada president to advisory committee.
- US biotech company files provisional patent application for psilocybin product.
- Mindset Pharma begins preclinical work on novel psychedelics.
- Australian charity suggests using psychedelic therapy to treat mental health issues.
THE OCEANIA CANNABIS REPORT: SECOND EDITION
Prohibition Partners is proud to launch The Oceania Cannabis Report: Second Edition. The report contains expert analysis on the latest industry developments across Australia, New Zealand and the surrounding islands, which is set to be worth $US1.55 billion by 2024.